Mesenchymal stem cells-derived exosomes for drug delivery
Y Sun, G Liu, K Zhang, Q Cao, T Liu, J Li - Stem cell research & therapy, 2021 - Springer
Exosomes are extracellular vesicles secreted by various cells, mainly composed of lipid
bilayers without organelles. In recent years, an increasing number of researchers have …
bilayers without organelles. In recent years, an increasing number of researchers have …
Extracellular vesicles and particles impact the systemic landscape of cancer
Intercellular cross talk between cancer cells and stromal and immune cells is essential for
tumor progression and metastasis. Extracellular vesicles and particles (EVPs) are a …
tumor progression and metastasis. Extracellular vesicles and particles (EVPs) are a …
Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer
A Dalmizrak, O Dalmizrak - Frontiers in Bioengineering and …, 2022 - frontiersin.org
Although ongoing medical research is working to find a cure for a variety of cancers, it
continues to be one of the major causes of death worldwide. Chemotherapy and …
continues to be one of the major causes of death worldwide. Chemotherapy and …
[HTML][HTML] Mesenchymal stem cell-derived extracellular vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity
C Shan, Y Liang, K Wang, P Li - International Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Mesenchymal stem cells (MSCs) are a type of stromal cells characterized by their properties
of self-renewal and multi-lineage differentiation, which make them prominent in regenerative …
of self-renewal and multi-lineage differentiation, which make them prominent in regenerative …
Adipose stem cells-released extracellular vesicles as a next-generation cargo delivery vehicles: a survey of minimal information implementation, mass production and …
J Chen, R Liu, T Huang, H Sun, H Jiang - Stem Cell Research & Therapy, 2022 - Springer
Objectives To investigate current situation of minimal information implementation highlighted
by minimal information for studies of extracellular vesicles 2018 (MISEV2018) guidelines …
by minimal information for studies of extracellular vesicles 2018 (MISEV2018) guidelines …
Role of non-coding RNAs in neuroblastoma
AA Anoushirvani, A Jafarian Yazdi, S Amirabadi… - Cancer Gene …, 2023 - nature.com
Neuroblastoma is known as the most prevalent extracranial malignancy in childhood with a
neural crest origin. It has been widely accepted that non-coding RNAs (ncRNAs) play …
neural crest origin. It has been widely accepted that non-coding RNAs (ncRNAs) play …
Mesenchymal stromal cells in neuroblastoma: exploring crosstalk and therapeutic implications
C Hochheuser, LJ Windt, NY Kunze… - Stem cells and …, 2021 - liebertpub.com
Neuroblastoma (NB) is the second most common solid cancer in childhood, accounting for
15% of cancer-related deaths in children. In high-risk NB patients, the majority suffers from …
15% of cancer-related deaths in children. In high-risk NB patients, the majority suffers from …
Glioblastoma therapy: rationale for a mesenchymal stem cell-based vehicle to carry recombinant viruses
S Ali, Q Xia, T Muhammad, L Liu, X Meng… - Stem Cell Reviews and …, 2021 - Springer
Evasion of growth suppression is among the prominent hallmarks of cancer. Phosphatase
and tensin homolog (PTEN) and p53 tumor-suppressive pathways are compromised in most …
and tensin homolog (PTEN) and p53 tumor-suppressive pathways are compromised in most …
[HTML][HTML] Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
AR Farina, LA Cappabianca, V Zelli… - World Journal of Stem …, 2021 - ncbi.nlm.nih.gov
Pediatric neuroblastomas (NBs) are heterogeneous, aggressive, therapy-resistant
embryonal tumours that originate from cells of neural crest (NC) origin and in particular …
embryonal tumours that originate from cells of neural crest (NC) origin and in particular …
Exosomes as neurological nanosized machines
E Pishavar, M Trentini, F Zanotti… - ACS Nanoscience …, 2022 - ACS Publications
In the past few decades, nanomedicine research has advanced dramatically. In spite of this,
traditional nanomedicine faces major obstacles, such as blood–brain barriers, low …
traditional nanomedicine faces major obstacles, such as blood–brain barriers, low …